5. Glatopa (Generic Form of Copaxone)
Glatopa, a generic form of Copaxone, is a glatiramer acetate injection designed to treat patients with relapsing and remitting forms of multiple sclerosis (RRMS). Approved for this indication by the U.S. Food and Drug Administration (FDA), it is manufactured and marketed jointly by Momenta and Sandoz (a Novartis company). The formulation aims to reduce the intensity of flares or exacerbations in RRMS patients and to increase the time interval between relapses, so as to reduce disease progression.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?